MondayNov 03, 2008 5:32 am

Shine Media Acquisition Corporation (OTC BB: SHND)

Shine Media Acquisition Corporation (OTC BB: SHND) is a young company located in China that was founded in 2005. Shine Media intends to acquire a direct or indirect ownership through a merger, capital stock exchange, asset or stock acquisition, other similar business combination, or control through contractual arrangements of one or more operating businesses in the media and advertising industry in China. Shine Media is led by their CEO, President and Director David Chen who is a renowned name in the advertising industry in China. For further information, visit the company website at: www.shndu.com.

Continue Reading

MondayNov 03, 2008 5:32 am

Cleveland BioLabs, Inc. (NASDAQ: CBLI)

Cleveland BioLabs, Inc. (NASDAQ: CBLI), a drug discovery and development company, is focused on using its proprietary discoveries to develop treatments for cancer and protection of normal tissues from exposure to radiation and other stresses. The company’s pipeline includes products from two primary families of compounds: Protectans and Curaxins. Protectans are being developed as drug candidates that protect normal tissues from acute stresses such as radiation, chemotherapy and ischemias, while Curaxins are being developed as anticancer agents that may function as mono-therapy drugs. For further information, visit the Company's web site at www.cbiolabs.com.

Continue Reading

MondayNov 03, 2008 5:32 am

Sherwood Copper Corp. (TSX: SWC CN)

Sherwood Copper Corp. (TSX: SWC CN) has its primary focus on profitably producing and developing high grade, open pit base and precious metals mines in Canada. The company’s high grade Minto copper-gold mine began commercial production in October of last year and is currently undergoing an expansion and optimization process. Additionally, the Company is advancing its high grade Kutcho copper project towards a production decision. For further information, visit the Company's web site at www.sherwoodcopper.com.

Continue Reading

MondayNov 03, 2008 5:31 am

Clarient, Inc. (NASDAQ: CLRT)

Clarient, Inc. (NASDAQ: CLRT) is focused on providing services, resources and critical information that improve the quality of life of patients, while reducing the cost of patient care. Pathologists, oncologists, hospitals and biopharmaceutical companies are the company’s primary customers. Clarient’s state-of-the-art commercial cancer laboratory provides the most sophisticated oncology testing and drug development services available both onsite and over the web. For further information, visit the Company's web site at www.clarientinc.com.

Continue Reading

MondayNov 03, 2008 5:31 am

Shengtai Pharmaceutical Inc., (OTC BB: SGTI)

Shengtai Pharmaceutical Inc., (OTC BB: SGTI) is China's leading manufacturer and supplier of pharmaceutical grade glucose for medicinal purposes. In addition to their pharmaceutical glucose series of products, they also produce other medicinal product lines as well such as industrial glucose, syrup, starch, avermectins, dextrin, maltose and maltitol, which are used for food, beverage and industrial production. Based in China, Shengtai has an international client-base. For further information, visit the company website at: www.shengtaipharmaceutical.com.

Continue Reading

MondayNov 03, 2008 5:31 am

ChinaCast Education Corporation (NASDAQ: CAST)

ChinaCast Education Corporation (NASDAQ: CAST), a leading for-profit, post-secondary education and e-learning services provider in China, provides its education services through a 80% ownership in the holding company of the Foreign Trade and Business College (FTBC) of Chongqing Normal University. FTBC offers fully-accredited, career-oriented bachelor's degree and diploma programs in business, economics, trade, tourism management, advertising, language, IT and music. For further information, visit the Company's web site at www.ir.chinacast.com.cn.

Continue Reading

MondayNov 03, 2008 5:31 am

Shengkai Company Ltd. (OTC BB: SOSA)

Shengkai Company Ltd. (OTC BB: SOSA) is an enterprise with high and new technology registered in the Economic & Technical Development Area of Tianjin, PRC. The key technology is the development, design and manufacture of the ceramic materials. SK products have been widely applied in various industries such as petroleum and aerospace. The company is led by Wang Chen and has applied for more than 10 patents. For further information, visit the company website at: www.Shenkai.com.

Continue Reading

MondayNov 03, 2008 5:30 am

Sequenom, Inc. (NASDAQ: SQNM)

Sequenom, Inc. (NASDAQ: SQNM) is focused on providing superior genetic analysis products designed to translate genomic science into advanced solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research, and possibly clinical utility. MassARRAY, the company’s high-performance DNA analysis platform, efficiently and precisely measures the amount of genetic target material as well as the variations within. For further information, visit the Company's web site at www.sequenom.com.

Continue Reading

MondayNov 03, 2008 5:30 am

China Yingxia International Inc. (OTC BB: CYXI)

China Yingxia International Inc. (OTC BB: CYXI), a leading health and nutritional foods company based in the Peoples Republic of China, has a product portfolio that includes hundreds of different products categorized into five product lines: nutritional foods, dietary supplements, raw cactus products, cosmetic products, and personal care & other products. The company’s products are sold throughout China as well as around the globe. For further information, visit the Company's web site at www.chinayingxia.com.

Continue Reading

MondayNov 03, 2008 5:30 am

Sepracor, Inc. (NASDAQ: SEPR)

Sepracor, Inc. (NASDAQ: SEPR), a research-based pharmaceutical company, has focused their efforts on treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products designed to serve large and growing markets. The company’s drug development program has proven its success by yielding a portfolio of pharmaceutical products and candidates. The focus of the program is on treating respiratory and central nervous system (CNS) disorders. For further information, visit the Company's web site at www.sepracor.com.

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered